The largest database of trusted experimental protocols

Pd0325901

Manufactured by InvivoGen
Sourced in France

PD0325901 is a small-molecule inhibitor of the Mitogen-Activated Protein Kinase Kinase (MEK) enzyme. It acts by inhibiting the phosphorylation and activation of the Extracellular Signal-Regulated Kinase (ERK) signaling pathway.

Automatically generated - may contain errors

5 protocols using pd0325901

1

Culturing and Differentiating Mouse Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
E14 (obtained from the American Type Culture Collection) and F1 (M. musculus129 × M. castaneus obtained from Barbara Panning) mouse ES cells were cultured on 0.1% gelatin-coated plates in ES medium (DMEM containing 15% FBS, 0.1 mM MEM nonessential amino acids, 1 mM sodium pyruvate, 2 mM GlutaMAX, 0.1 mM 2-mercaptoethanol, 1000 U/mL LIF, 3 μM CHIR99021 [GSK3β inhibitor, Biovision], 1 μM PD0325901 [MEK inhibitor, Invivogen]) and maintained in a pluripotent state in the absence of a feeder layer (Mlynarczyk-Evans et al. 2006 (link); Ying et al. 2008 (link)). MEFs were isolated from embryonic day 12.5 (E12.5) C57Bl/6 mouse embryos and cultured in DMEM containing 10% FBS and 2 mM GlutaMAX. F1 TS cells (M. musculusC57BL/6 × M. castaneus, obtained from Susannah Varmuza) were maintained as described in Tanaka (2006) (link) (Miri et al. 2013 (link)). EBs were formed by the hanging drop method; to initiate differentiation, 1000 cells were suspended in 20-μL droplets of ES medium without LIF and 2i (Ohnuki and Kurosawa 2013 (link)). EBs were transferred to 0.1% gelatin on day 4 to facilitate further growth. EBs were collected at daily intervals up to day 12, and RNA was isolated for gene expression analysis by RT-qPCR. All animal experiments were approved by the University Animal Care Committee (UACC) at the University of Toronto and the Bioscience Local Animal Care Committee (LACC).
+ Open protocol
+ Expand
2

Feeder-free Mouse Embryonic Stem Cell Culture and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse ESCs (E14TG2a; ATCC [CRL-1821]), were maintained in feeder-free conditions on 0.1% gelatin in DMEM supplemented with 15% (v/v) fetal bovine serum (FBS), 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 2 mM GlutaMAX, 0.1 mM 2-mercaptoethanol, 1,000 U/mL LIF, 3 μM CHIR99021 (GSK3β inhibitor, Biovision) and 1 μM PD0325901 (MEK inhibitor, Invivogen); referred to as LIF/2i medium. The differentiation medium contained the same components with the exception of LIF/2i. For FGFR inhibition, the MEK inhibitor was replaced with 25 nM PD173074 (Selleckchem). For TPA (NEB) treatment, cells were cultured overnight in low serum (0.2%) ESC medium, followed by treatment with 200 nM TPA in the absence of LIF/2i. For ESCs maintained in LIF alone, cells were cultured in ESC medium containing LIF without 2i for 8–10 passages before removal of LIF to induce differentiation. For evaluation of AP activity, cells were seeded at 250 cells/well in a 12-well plate and allowed to differentiate for 5 days. AP staining (Millipore) was performed following the manufacturer’s instructions. EBs were formed by the hanging-drop method; 1,000 cells were suspended in 20-μL droplets of ESC medium without LIF/2i (Ohnuki and Kurosawa, 2013 (link)). EBs were transferred to 0.1% gelatin on day 4, and collected until day 12; RNA was isolated for gene expression analysis by qRT-PCR.
+ Open protocol
+ Expand
3

Tularemia Infection Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 65 female 6- to 8-week-old Balb/c mice (Charles River Laboratories, UK) were separated into four groups: group I (20 mice), group II (20 mice), group III (15 mice) and group IV (10 mice). All mice, except those in group IV, were treated daily with either PBS or 0.05 μM PD0325901 (InvivoGen, France) by oral-gavage in a volume of 100 μl. Groups I and II were treated from 24 h pre-infection, while group III was treated from 48 h post-infection. The mice were infected via the intranasal route with approximately 2.5 × 104 CFU of F. tularensis strain LVS. Scoring of the mice occurred twice daily throughout the study. At 48 h and 96 h post-challenge, five mice from each of groups I, II, III, and IV were culled and the lungs, liver, and spleen were removed and placed into aliquots of 2 ml PBS. Ten mice from each of groups I, II, III, and IV were monitored for changes in survival. Organs were homogenised though a 0.2 μm cell sieve (BD Biosciences) and screened for the levels of cytokines, activation of signalling proteins and bacterial enumeration on agar. All animal studies were carried out in accordance with the UK Scientific Procedures Act (1986). Animal handling and infection procedures were carried out by trained staff at Dstl.
+ Open protocol
+ Expand
4

Inhibition of MEK1/2 Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEK-1/2 inhibitor PD0325901 obtained from InvivoGen (Toulouse, France) and U0126 obtained from Sigma (Sigma-Aldrich, Lyon, France) were used as recommended by supplier. PD0325901 is a selective non-ATP-competitive allosteric MEK1/2 inhibitor with in vitro IC50 0.33 nM, which was shown to be specific against a panel of 70 different kinases at 10 µM range (54 (link)). U0126 inhibits MEK 1/2 with an in vitro IC50 of 0.5 µM. JNK inhibitor SP600125, TBK1 inhibitor BX795, NF-ĸB inhibitor Bay11-7082, p38 MAPK inhibitor SB253080, and calcineurin inhibitor FK506 were all purchased from InvivoGen, San Diego, USA. For in vitro pDC stimulation assays, CpG-A (ODN 2216), CpG-B (ODN 2006), and PMA (all InvivoGen, San Diego, USA), and BDCA-2 antibody (Miltenyi Biotech, Paris, France), and ILT7 antibody (eBioscience) were used.
+ Open protocol
+ Expand
5

Investigating B. pseudomallei Infection in MH-S Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MH-S cells were infected with B. pseudomallei at an MOI of 10 (equivalent to t = −30 min) and the cells were allowed to internalise bacteria for a further 30 min. Control cells were left uninfected (naïve). The media was removed, cells were washed with PBS and fresh media applied (equivalent to t = 0 h). The ERK inhibitor PD0325901 (InvivoGen @ 0.05 μM) was added to the cells at either 0 h or 2 h after the cells were washed of non-internalised bacteria. At multiple time points after infection, supernatants and cell lysates were collected for cytokine analysis, screening for signalling protein activation and bacterial enumeration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!